{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:12:42Z","timestamp":1790741562240,"version":"4.1.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204405"],"award-info":[{"award-number":["82204405"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-025-01503-w","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:51:10Z","timestamp":1763549470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["From pathogenesis to therapeutic targeting: new insight into TAM receptors in rheumatoid arthritis"],"prefix":"10.1186","volume":"15","author":[{"given":"Mengli","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weirong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renpeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-3732","authenticated-orcid":false,"given":"Yingjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"1503_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. 2023;8:68.","journal-title":"Signal Transduct Target Ther"},{"key":"1503_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","volume":"9","author":"Y Song","year":"2024","unstructured":"Song Y, Li J, Wu Y. Evolving Understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduct Target Ther. 2024;9:263.","journal-title":"Signal Transduct Target Ther"},{"key":"1503_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.ircmb.2021.02.002","volume":"361","author":"L Zhou","year":"2021","unstructured":"Zhou L, Matsushima GK. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment. Int Rev Cell Mol Biol. 2021;361:165\u2013210.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1503_CR4","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41467-024-46564-6","volume":"15","author":"A Nerviani","year":"2024","unstructured":"Nerviani A, Boutet MA, Ghirardi GM, Goldmann K, Sciacca E, Rivellese F, et al. Axl and MerTK regulate synovial inflammation and are modulated by IL-6 Inhibition in rheumatoid arthritis. Nat Commun. 2024;15:2398.","journal-title":"Nat Commun"},{"key":"1503_CR5","doi-asserted-by":"publisher","first-page":"e0205902","DOI":"10.1371\/journal.pone.0205902","volume":"13","author":"CEJ Waterborg","year":"2018","unstructured":"Waterborg CEJ, Koenders MI, van Lent P, van der Kraan PM, van de Loo FAJ. Tyro3\/Axl\/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis. PLoS ONE. 2018;13:e0205902.","journal-title":"PLoS ONE"},{"key":"1503_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12964-023-01133-0","volume":"21","author":"L Gao","year":"2023","unstructured":"Gao L, He C, Yang A, Zhou H, Lu Q, Birge RB, et al. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis. Cell Commun Signal. 2023;21:195.","journal-title":"Cell Commun Signal"},{"key":"1503_CR7","doi-asserted-by":"crossref","unstructured":"Prieto AL, Lai C. The TAM subfamily of receptor tyrosine kinases: the early years. Int J Mol Sci, 2024;25.","DOI":"10.3390\/ijms25063369"},{"key":"1503_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.ircmb.2020.09.002","volume":"357","author":"K Geng","year":"2020","unstructured":"Geng K. Post-translational modifications of the ligands: requirement for TAM receptor activation. Int Rev Cell Mol Biol. 2020;357:35\u201355.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1503_CR9","doi-asserted-by":"crossref","unstructured":"Gilchrist SE, Pennelli GM, Hafizi S. Gas6\/TAM signalling negatively regulates inflammatory induction of GM-CSF in mouse brain microglia. Cells, 2021;10.","DOI":"10.3390\/cells10123281"},{"key":"1503_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41573-023-00846-8","volume":"23","author":"YR Miao","year":"2024","unstructured":"Miao YR, Rankin EB, Giaccia AJ. Therapeutic targeting of the functionally elusive TAM receptor family. Nat Rev Drug Discov. 2024;23:201\u201317.","journal-title":"Nat Rev Drug Discov"},{"key":"1503_CR11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3389\/fimmu.2017.01521","volume":"8","author":"K Geng","year":"2017","unstructured":"Geng K, Kumar S, Kimani SG, Kholodovych V, Kasikara C, Mizuno K, et al. Requirement of Gamma-Carboxyglutamic acid modification and phosphatidylserine binding for the activation of Tyro3, Axl, and Mertk receptors by growth Arrest-Specific 6. Front Immunol. 2017;8:1521.","journal-title":"Front Immunol"},{"key":"1503_CR12","doi-asserted-by":"crossref","unstructured":"Lew ED, Oh J, Burrola PG, Lax I, Zag\u00f3rska A, Trav\u00e9s PG et al. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Elife, 2014;3.","DOI":"10.7554\/eLife.03385"},{"key":"1503_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/1541-7786.MCR-16-0350","volume":"15","author":"C Kasikara","year":"2017","unstructured":"Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, et al. Phosphatidylserine sensing by TAM receptors regulates AKT-Dependent chemoresistance and PD-L1 expression. Mol Cancer Res. 2017;15:753\u201364.","journal-title":"Mol Cancer Res"},{"key":"1503_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41571-023-00813-7","volume":"20","author":"D DeRyckere","year":"2023","unstructured":"DeRyckere D, Huelse JM, Earp HS. Graham. TAM family kinases as therapeutic targets at the interface of cancer and immunity. Nat Rev Clin Oncol. 2023;20:755\u201379.","journal-title":"Nat Rev Clin Oncol"},{"key":"1503_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molimm.2016.06.016","volume":"76","author":"B Zhang","year":"2016","unstructured":"Zhang B, Fang L, Wu HM, Ding PS, Xu K. Liu. Mer receptor tyrosine kinase negatively regulates Lipoteichoic acid-induced inflammatory response via PI3K\/Akt and SOCS3. Mol Immunol. 2016;76:98\u2013107.","journal-title":"Mol Immunol"},{"key":"1503_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB. Lemke. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007;131:1124\u201336.","journal-title":"Cell"},{"key":"1503_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/blood-2006-04-017368","volume":"109","author":"P Sen","year":"2007","unstructured":"Sen P, Wallet MA, Yi Z, Huang Y, Henderson M, Mathews CE, et al. Apoptotic cells induce Mer tyrosine kinase-dependent Blockade of NF-kappaB activation in dendritic cells. Blood. 2007;109:653\u201360.","journal-title":"Blood"},{"key":"1503_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13045-018-0584-6","volume":"11","author":"C Shi","year":"2018","unstructured":"Shi C, Li X, Wang X, Ding N, Ping L, Shi Y, et al. The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma. J Hematol Oncol. 2018;11:43.","journal-title":"J Hematol Oncol"},{"key":"1503_CR19","doi-asserted-by":"publisher","first-page":"1007165","DOI":"10.3389\/fimmu.2022.1007165","volume":"13","author":"T Zhao","year":"2022","unstructured":"Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z, et al. Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities. Front Immunol. 2022;13:1007165.","journal-title":"Front Immunol"},{"key":"1503_CR20","doi-asserted-by":"publisher","first-page":"564133","DOI":"10.3389\/fimmu.2020.564133","volume":"11","author":"P Giroud","year":"2020","unstructured":"Giroud P, Renaudineau S, Gudefin L, Calcei A, Menguy T, Rozan C, et al. Expression of TAM-R in human immune cells and unique regulatory function of MerTK in IL-10 production by tolerogenic DC. Front Immunol. 2020;11:564133.","journal-title":"Front Immunol"},{"key":"1503_CR21","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1136\/annrheumdis-2019-215881","volume":"79","author":"MH Buch","year":"2020","unstructured":"Buch MH, Melville A. McGonagle. \u2018Synovial cellular and molecular signatures stratify clinical response to CsDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients\u2019. Ann Rheum Dis. 2020;79:e140.","journal-title":"Ann Rheum Dis"},{"key":"1503_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/cei\/uxac071","volume":"209","author":"L Zheng","year":"2022","unstructured":"Zheng L, Xu L, Hu F, Xue J, Bai M, Yao R, et al. Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis. Clin Exp Immunol. 2022;209:270\u20139.","journal-title":"Clin Exp Immunol"},{"key":"1503_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13075-020-02308-7","volume":"22","author":"J Xue","year":"2020","unstructured":"Xue J, Xu L, Zhu H, Bai M, Li X, Zhao Z, et al. CD14(+)CD16(-) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Res Ther. 2020;22:221.","journal-title":"Arthritis Res Ther"},{"key":"1503_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/rheumatology\/key337","volume":"58","author":"CEJ Waterborg","year":"2019","unstructured":"Waterborg CEJ, Broeren MGA, Blaney Davidson EN, Koenders MI, van Lent P, van den Berg WB, et al. The level of synovial AXL expression determines the outcome of inflammatory arthritis, possibly depending on the upstream role of TGF-\u03b21. Rheumatology (Oxford). 2019;58:536\u201346.","journal-title":"Rheumatology (Oxford)"},{"key":"1503_CR25","doi-asserted-by":"publisher","first-page":"15877","DOI":"10.1038\/ncomms15877","volume":"8","author":"M Kurowska-Stolarska","year":"2017","unstructured":"Kurowska-Stolarska M, Alivernini S, Melchor EG, Elmesmari A, Tolusso B, Tange C, et al. MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis. Nat Commun. 2017;8:15877.","journal-title":"Nat Commun"},{"key":"1503_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2016.05.011","volume":"169","author":"JJ Orme","year":"2016","unstructured":"Orme JJ, Du Y, Vanarsa K, Mayeux J, Li L, Mutwally A, et al. Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases May contribute to disease pathogenesis in SLE. Clin Immunol. 2016;169:58\u201368.","journal-title":"Clin Immunol"},{"key":"1503_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00262-019-02421-w","volume":"69","author":"MJW Peeters","year":"2020","unstructured":"Peeters MJW, Rahbech A, Thor Straten P. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting. Cancer Immunol Immunother. 2020;69:237\u201344.","journal-title":"Cancer Immunol Immunother"},{"key":"1503_CR28","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1172\/JCI39325","volume":"119","author":"T Burstyn-Cohen","year":"2009","unstructured":"Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest. 2009;119:2942\u201353.","journal-title":"J Clin Invest"},{"key":"1503_CR29","doi-asserted-by":"publisher","first-page":"6848430","DOI":"10.1155\/2017\/6848430","volume":"2017","author":"GJ Zhao","year":"2017","unstructured":"Zhao GJ, Zheng JY, Bian JL, Chen LW, Dong N, Yu Y, et al. Growth Arrest-Specific 6 enhances the suppressive function of CD4(+)CD25(+) regulatory T cells mainly through Axl receptor. Mediators Inflamm. 2017;2017:6848430.","journal-title":"Mediators Inflamm"},{"key":"1503_CR30","doi-asserted-by":"crossref","unstructured":"Lee-Sherick AB, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS et al. MERTK Inhibition alters the PD-1 axis and promotes anti-leukemia immunity. JCI Insight, 2020;5.","DOI":"10.1172\/jci.insight.145847"},{"key":"1503_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/art.37786","volume":"65","author":"BT van den Brand","year":"2013","unstructured":"van den Brand BT, Abdollahi-Roodsaz S, Vermeij EA, Bennink MB, Arntz OJ, Rothlin CV, et al. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis. Arthritis Rheum. 2013;65:671\u201380.","journal-title":"Arthritis Rheum"},{"key":"1503_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.aaf1358","volume":"352","author":"PY Chan","year":"2016","unstructured":"Chan PY, Carrera Silva EA, De Kouchkovsky D, Joannas LD, Hao L, Hu D, et al. The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity. Science. 2016;352:99\u2013103.","journal-title":"Science"},{"key":"1503_CR33","doi-asserted-by":"publisher","first-page":"13898","DOI":"10.1038\/ncomms13898","volume":"7","author":"TA Aguilera","year":"2016","unstructured":"Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS, Hui AB, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898.","journal-title":"Nat Commun"},{"key":"1503_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/2326-6066.CIR-18-0841","volume":"7","author":"MJW Peeters","year":"2019","unstructured":"Peeters MJW, Dulkeviciute D, Draghi A, Ritter C, Rahbech A, Skadborg SK, et al. MERTK acts as a costimulatory receptor on human CD8(+) T cells. Cancer Immunol Res. 2019;7:1472\u201384.","journal-title":"Cancer Immunol Res"},{"key":"1503_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","volume":"18","author":"M Kurowska-Stolarska","year":"2022","unstructured":"Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Rev Rheumatol. 2022;18:384\u201397.","journal-title":"Nat Rev Rheumatol"},{"key":"1503_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s13018-024-05052-9","volume":"19","author":"X Yin","year":"2024","unstructured":"Yin X, Wang Q, Tang Y, Wang T, Zhang Y. Yu. Research progress on macrophage polarization during osteoarthritis disease progression: a review. J Orthop Surg Res. 2024;19:584.","journal-title":"J Orthop Surg Res"},{"key":"1503_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","volume":"19","author":"G Lemke","year":"2019","unstructured":"Lemke G. How macrophages deal with death. Nat Rev Immunol. 2019;19:539\u201349.","journal-title":"Nat Rev Immunol"},{"key":"1503_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.it.2024.06.004","volume":"45","author":"MF Neurath","year":"2024","unstructured":"Neurath MF. Berg. VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases. Trends Immunol. 2024;45:580\u201396.","journal-title":"Trends Immunol"},{"key":"1503_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","volume":"18","author":"KV Myers","year":"2019","unstructured":"Myers KV, Amend SR. Pienta. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer. 2019;18:94.","journal-title":"Mol Cancer"},{"key":"1503_CR40","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1080\/15548627.2016.1235124","volume":"12","author":"J Han","year":"2016","unstructured":"Han J, Bae J, Choi CY, Choi SP, Kang HS, Jo EK, et al. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via Inhibition of NLRP3 inflammasome activation in mice. Autophagy. 2016;12:2326\u201343.","journal-title":"Autophagy"},{"key":"1503_CR41","doi-asserted-by":"crossref","unstructured":"Ghosh S, Finnemann SC, Vollrath D. C. V. Rothlin. In the eyes of the Beholder-New Mertk knockout mouse and Re-Evaluation of phagocytosis versus Anti-Inflammatory functions of MERTK. Int J Mol Sci, 2024;25.","DOI":"10.3390\/ijms25105299"},{"key":"1503_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2017.11.009","volume":"110","author":"G Wu","year":"2018","unstructured":"Wu G, McBride DW, Zhang JH. Axl activation attenuates neuroinflammation by inhibiting the TLR\/TRAF\/NF-\u03baB pathway after MCAO in rats. Neurobiol Dis. 2018;110:59\u201367.","journal-title":"Neurobiol Dis"},{"key":"1503_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","volume":"198","author":"E Vergadi","year":"2017","unstructured":"Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K. Tsatsanis. Akt signaling pathway in macrophage activation and M1\/M2 polarization. J Immunol. 2017;198:1006\u201314.","journal-title":"J Immunol"},{"key":"1503_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/imr.13214","volume":"319","author":"M Schilperoort","year":"2023","unstructured":"Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunol Rev. 2023;319:65\u201380.","journal-title":"Immunol Rev"},{"key":"1503_CR45","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1172\/JCI97354","volume":"128","author":"E Ubil","year":"2018","unstructured":"Ubil E, Caskey L, Holtzhausen A, Hunter D, Story C. Earp. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest. 2018;128:2356\u201369.","journal-title":"J Clin Invest"},{"key":"1503_CR46","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.joen.2018.07.005","volume":"44","author":"HW Yeh","year":"2018","unstructured":"Yeh HW, Chiang CF, Chen PH, Su CC, Wu YC, Chou L, et al. Axl involved in mineral trioxide aggregate induces macrophage polarization. J Endod. 2018;44:1542\u20138.","journal-title":"J Endod"},{"key":"1503_CR47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/1535-7163.MCT-22-0617","volume":"22","author":"R Ozyurt","year":"2023","unstructured":"Ozyurt R, Ozpolat B. Therapeutic landscape of AXL receptor kinase in Triple-Negative breast cancer. Mol Cancer Ther. 2023;22:818\u201332.","journal-title":"Mol Cancer Ther"},{"key":"1503_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","volume":"13","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC, Liu XQ, et al. Dendritic cell biology and its role in tumor immunotherapy. J Hematol Oncol. 2020;13:107.","journal-title":"J Hematol Oncol"},{"key":"1503_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1742-2094-8-49","volume":"8","author":"JG Weinger","year":"2011","unstructured":"Weinger JG, Brosnan CF, Loudig O, Goldberg MF, Macian F, Arnett HA, et al. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of Myelin debris during experimental autoimmune encephalomyelitis. J Neuroinflammation. 2011;8:49.","journal-title":"J Neuroinflammation"},{"key":"1503_CR50","doi-asserted-by":"publisher","first-page":"960401","DOI":"10.3389\/fimmu.2022.960401","volume":"13","author":"L Jim\u00e9nez-Garc\u00eda","year":"2022","unstructured":"Jim\u00e9nez-Garc\u00eda L, Mayer C, Burrola PG, Huang Y, Shokhirev MN. Lemke. The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages. Front Immunol. 2022;13:960401.","journal-title":"Front Immunol"},{"key":"1503_CR51","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1182\/blood-2009-03-207522","volume":"114","author":"Z Yi","year":"2009","unstructured":"Yi Z, Li L, Matsushima GK, Earp HS, Wang B, Tisch R. A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells. Blood. 2009;114:3191\u20138.","journal-title":"Blood"},{"key":"1503_CR52","doi-asserted-by":"crossref","unstructured":"Li V, Binder MD. T. J. Kilpatrick. The tolerogenic influence of dexamethasone on dendritic cells is accompanied by the induction of Efferocytosis, promoted by MERTK. Int J Mol Sci, 2023;24.","DOI":"10.3390\/ijms242115903"},{"key":"1503_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu S, Galat V, Galat Y, Lee YKA, Wainwright D. Wu. NK cell-based cancer immunotherapy: from basic biology to clinical development. J Hematol Oncol. 2021;14:7.","journal-title":"J Hematol Oncol"},{"key":"1503_CR54","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1182\/blood-2008-05-157073","volume":"113","author":"IK Park","year":"2009","unstructured":"Park IK, Giovenzana C, Hughes TL, Yu J, Trotta R. Caligiuri. The Axl\/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood. 2009;113:2470\u20137.","journal-title":"Blood"},{"key":"1503_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ni1353","volume":"7","author":"A Caraux","year":"2006","unstructured":"Caraux A, Lu Q, Fernandez N, Riou S, Di Santo JP, Raulet DH, et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol. 2006;7:747\u201354.","journal-title":"Nat Immunol"},{"key":"1503_CR56","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.3389\/fimmu.2019.02590","volume":"10","author":"D Gotthardt","year":"2019","unstructured":"Gotthardt D, Trifinopoulos J, Sexl V. Putz. JAK\/STAT cytokine signaling at the crossroad of NK cell development and maturation. Front Immunol. 2019;10:2590.","journal-title":"Front Immunol"},{"key":"1503_CR57","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.drudis.2020.09.022","volume":"25","author":"R Di Stasi","year":"2020","unstructured":"Di Stasi R, De Rosa L. D\u2019Andrea. Therapeutic aspects of the Axl\/Gas6 molecular system. Drug Discov Today. 2020;25:2130\u201348.","journal-title":"Drug Discov Today"},{"key":"1503_CR58","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3389\/fimmu.2019.01261","volume":"10","author":"AJ Lee","year":"2019","unstructured":"Lee AJ, Mian F, Poznanski SM, Stackaruk M, Chan T, Chew MV, et al. Type I interferon receptor on NK cells negatively regulates interferon-\u03b3 production. Front Immunol. 2019;10:1261.","journal-title":"Front Immunol"},{"key":"1503_CR59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2020.00297","volume":"11","author":"L Ireland","year":"2020","unstructured":"Ireland L, Luckett T, Schmid MC, Mielgo A. Blockade of stromal Gas6 alters cancer cell Plasticity, activates NK cells, and inhibits pancreatic cancer metastasis. Front Immunol. 2020;11:297.","journal-title":"Front Immunol"},{"key":"1503_CR60","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00709-016-1016-5","volume":"254","author":"EM Kim","year":"2017","unstructured":"Kim EM, Lee EH, Lee HY, Choi HR, Ji KY, Kim SM, et al. Axl signaling induces development of natural killer cells in vitro and in vivo. Protoplasma. 2017;254:1091\u2013101.","journal-title":"Protoplasma"},{"key":"1503_CR61","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/2326-6066.CIR-20-1014","volume":"9","author":"T Lu","year":"2021","unstructured":"Lu T, Ma R, Li Z, Mansour AG, Teng KY, Chen L, et al. Hijacking TYRO3 from tumor cells via trogocytosis enhances NK-cell effector functions and proliferation. Cancer Immunol Res. 2021;9:1229\u201341.","journal-title":"Cancer Immunol Res"},{"key":"1503_CR62","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature12998","volume":"507","author":"M Paolino","year":"2014","unstructured":"Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature. 2014;507:508\u201312.","journal-title":"Nature"},{"key":"1503_CR63","doi-asserted-by":"publisher","first-page":"ra54","DOI":"10.1126\/scisignal.aad6182","volume":"9","author":"O Matalon","year":"2016","unstructured":"Matalon O, Fried S, Ben-Shmuel A, Pauker MH, Joseph N, Keizer D, et al. Dephosphorylation of the adaptor LAT and phospholipase C-\u03b3 by SHP-1 inhibits natural killer cell cytotoxicity. Sci Signal. 2016;9:ra54.","journal-title":"Sci Signal"},{"key":"1503_CR64","doi-asserted-by":"crossref","unstructured":"Fu X, Liu H, Huang G, Dai SS. The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets. MedComm (2020), 2021;2:402\u2009\u2013\u200913.","DOI":"10.1002\/mco2.69"},{"key":"1503_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/art.30141","volume":"63","author":"N Tsuboi","year":"2011","unstructured":"Tsuboi N, Ernandez T, Li X, Nishi H, Cullere X, Mekala D, et al. Regulation of human neutrophil Fc\u03b3 receptor IIa by C5a receptor promotes inflammatory arthritis in mice. Arthritis Rheum. 2011;63:467\u201378.","journal-title":"Arthritis Rheum"},{"key":"1503_CR66","doi-asserted-by":"publisher","first-page":"166490","DOI":"10.1016\/j.bbadis.2022.166490","volume":"1868","author":"J Bao","year":"2022","unstructured":"Bao J, Zhang X, Li B, Niu M, Wu Z, Song P, et al. AXL and MERTK receptor tyrosine kinases Inhibition protects against pancreatic necrosis via selectively limiting CXCL2-related neutrophil infiltration. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166490.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1503_CR67","doi-asserted-by":"publisher","first-page":"750753","DOI":"10.3389\/fimmu.2021.750753","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects. Front Immunol. 2021;12:750753.","journal-title":"Front Immunol"},{"key":"1503_CR68","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4049\/jimmunol.1200824","volume":"190","author":"TN Khan","year":"2013","unstructured":"Khan TN, Wong EB, Soni C, Rahman ZS. Prolonged apoptotic cell accumulation in germinal centers of Mer-deficient mice causes elevated B cell and CD4\u2009+\u2009Th cell responses leading to autoantibody production. J Immunol. 2013;190:1433\u201346.","journal-title":"J Immunol"},{"key":"1503_CR69","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3389\/fimmu.2020.01759","volume":"11","author":"S Farnworth-McHugh","year":"2020","unstructured":"Farnworth-McHugh S, Barth N, Melville L, Paterson M, Lynch C, Holland P, et al. Potential oncogenic effect of the MERTK-Dependent Apoptotic-Cell clearance pathway in Starry-Sky B-Cell lymphoma. Front Immunol. 2020;11:1759.","journal-title":"Front Immunol"},{"key":"1503_CR70","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.joca.2023.01.005","volume":"31","author":"A Loucks","year":"2023","unstructured":"Loucks A, Maerz T, Hankenson K, Moeser A, Colbath A. The multifaceted role of mast cells in joint inflammation and arthritis. Osteoarthritis Cartilage. 2023;31:567\u201375.","journal-title":"Osteoarthritis Cartilage"},{"key":"1503_CR71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s002770050443","volume":"77","author":"I Heide","year":"1998","unstructured":"Heide I, Sokoll AC, Henz BM, Nagel S, Kreissig K, Gr\u00fctzkau A, et al. Regulation and possible function of Axl expression in immature human mast cells. Ann Hematol. 1998;77:199\u2013205.","journal-title":"Ann Hematol"},{"key":"1503_CR72","doi-asserted-by":"publisher","first-page":"117490","DOI":"10.1016\/j.biopha.2024.117490","volume":"180","author":"Z Qu","year":"2024","unstructured":"Qu Z, Zhao S, Zhang Y, Wang X. Yan. Natural compounds for bone remodeling: targeting osteoblasts and relevant signaling pathways. Biomed Pharmacother. 2024;180:117490.","journal-title":"Biomed Pharmacother"},{"key":"1503_CR73","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1038\/s41467-022-33938-x","volume":"13","author":"J Engelmann","year":"2022","unstructured":"Engelmann J, Zarrer J, Gensch V, Riecken K, Berenbrok N, Luu TV, et al. Regulation of bone homeostasis by MERTK and TYRO3. Nat Commun. 2022;13:7689.","journal-title":"Nat Commun"},{"key":"1503_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10585-021-10093-z","volume":"38","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, Dykes SS, Siemann DW. Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling. Clin Exp Metastasis. 2021;38:321\u201335.","journal-title":"Clin Exp Metastasis"},{"key":"1503_CR75","doi-asserted-by":"crossref","unstructured":"Engelmann J, Ragipoglu D, Ben-Batalla I. S. Loges. The role of TAM receptors in bone. Int J Mol Sci, 2023;25.","DOI":"10.3390\/ijms25010233"},{"key":"1503_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-017-3023-z","volume":"433","author":"C Qiu","year":"2017","unstructured":"Qiu C, Zheng H, Tao H, Yu W, Jiang X, Li A, et al. Vitamin K2 inhibits rat vascular smooth muscle cell calcification by restoring the Gas6\/Axl\/Akt anti-apoptotic pathway. Mol Cell Biochem. 2017;433:149\u201359.","journal-title":"Mol Cell Biochem"},{"key":"1503_CR77","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/00220345231177996","volume":"102","author":"AM Decker","year":"2023","unstructured":"Decker AM, Matsumoto M, Decker JT, Roh A, Inohara N, Sugai J, et al. Inhibition of Mertk signaling enhances bone healing after tooth extraction. J Dent Res. 2023;102:1131\u201340.","journal-title":"J Dent Res"},{"key":"1503_CR78","doi-asserted-by":"crossref","unstructured":"Yahara Y, Nguyen T, Ishikawa K, Kamei K. B. A. Alman. The origins and roles of osteoclasts in bone development, homeostasis and repair. Development, 2022;149.","DOI":"10.1242\/dev.199908"},{"key":"1503_CR79","doi-asserted-by":"publisher","first-page":"9690832","DOI":"10.1155\/2020\/9690832","volume":"2020","author":"J Vullings","year":"2020","unstructured":"Vullings J, Vago JP, Waterborg CEJ, Thurlings RM, Koenders MI, van Lent P, et al. Selective increment of synovial soluble TYRO3 correlates with disease severity and joint inflammation in patients with rheumatoid arthritis. J Immunol Res. 2020;2020:9690832.","journal-title":"J Immunol Res"},{"key":"1503_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cei.13082","volume":"192","author":"L Xu","year":"2018","unstructured":"Xu L, Hu F, Zhu H, Liu X, Shi L, Li Y, et al. Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction. Clin Exp Immunol. 2018;192:95\u2013103.","journal-title":"Clin Exp Immunol"},{"key":"1503_CR81","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/annrheumdis-2012-202907","volume":"73","author":"G Ruiz-Heiland","year":"2014","unstructured":"Ruiz-Heiland G, Zhao Y, Derer A, Braun T, Engelke K, Neumann E, et al. Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis. Ann Rheum Dis. 2014;73:771\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1503_CR82","doi-asserted-by":"publisher","first-page":"e85630","DOI":"10.1172\/jci.insight.85630","volume":"1","author":"KA Minson","year":"2016","unstructured":"Minson KA, Smith CC, DeRyckere D, Libbrecht C, Lee-Sherick AB, Huey MG, et al. The MERTK\/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. JCI Insight. 2016;1:e85630.","journal-title":"JCI Insight"},{"key":"1503_CR83","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41401-022-01047-6","volume":"44","author":"JP Pei","year":"2023","unstructured":"Pei JP, Wang Y, Ma LP, Wang X, Liu L, Zhang Y, et al. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage. Acta Pharmacol Sin. 2023;44:1290\u2013303.","journal-title":"Acta Pharmacol Sin"},{"key":"1503_CR84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1158\/1535-7163.MCT-18-0537","volume":"18","author":"JM Quinn","year":"2019","unstructured":"Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, et al. Therapeutic Inhibition of the receptor tyrosine kinase AXL improves sensitivity to platinum and taxane in ovarian cancer. Mol Cancer Ther. 2019;18:389\u201398.","journal-title":"Mol Cancer Ther"},{"key":"1503_CR85","doi-asserted-by":"crossref","unstructured":"Tseng CC, Chen YJ, Chang WA, Tsai WC, Ou TT, Wu CC et al. Dual role of chondrocytes in rheumatoid arthritis: the chicken and the egg. Int J Mol Sci, 2020;21.","DOI":"10.3390\/ijms21031071"},{"key":"1503_CR86","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/art.1780400814","volume":"40","author":"RF Loeser","year":"1997","unstructured":"Loeser RF, Varnum BC, Carlson CS, Goldring MB, Liu ET, Sadiev S, et al. Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage. Arthritis Rheum. 1997;40:1455\u201365.","journal-title":"Arthritis Rheum"},{"key":"1503_CR87","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1210\/me.2009-0228","volume":"24","author":"MR Hutchison","year":"2010","unstructured":"Hutchison MR, Bassett MH. White. SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation. Mol Endocrinol. 2010;24:193\u2013203.","journal-title":"Mol Endocrinol"},{"key":"1503_CR88","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bbrc.2007.04.035","volume":"357","author":"H Motomura","year":"2007","unstructured":"Motomura H, Niimi H, Sugimori K, Ohtsuka T, Kimura T, Kitajima I. Gas6, a new regulator of chondrogenic differentiation from mesenchymal cells. Biochem Biophys Res Commun. 2007;357:997\u20131003.","journal-title":"Biochem Biophys Res Commun"},{"key":"1503_CR89","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. Defining inflammatory cell States in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20:928\u201342.","journal-title":"Nat Immunol"},{"key":"1503_CR90","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0002-9440(10)65369-2","volume":"154","author":"K O\u2019Donnell","year":"1999","unstructured":"O\u2019Donnell K, Harkes IC, Dougherty L, Wicks IP. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol. 1999;154:1171\u201380.","journal-title":"Am J Pathol"},{"key":"1503_CR91","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16:316\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"1503_CR92","doi-asserted-by":"publisher","first-page":"109753","DOI":"10.1016\/j.clim.2023.109753","volume":"255","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhao Z, Li Z, Xu L, Li H, Zhu H, et al. Tyro3 receptor tyrosine kinase contributes to pathogenic phenotypes of fibroblast-like synoviocytes in rheumatoid arthritis and disturbs immune cell balance in experimental arthritis. Clin Immunol. 2023;255:109753.","journal-title":"Clin Immunol"},{"key":"1503_CR93","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini S, MacDonald L, Elmesmari A, Finlay S, Tolusso B, Gigante MR, et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat Med. 2020;26:1295\u2013306.","journal-title":"Nat Med"},{"key":"1503_CR94","doi-asserted-by":"crossref","unstructured":"Vago JP, Valdrighi N, Blaney-Davidson EN, Hornikx D, Neefjes M, Barba-Sarasua ME et al. Gas6\/Axl axis activation dampens the inflammatory response in Osteoarthritic Fibroblast-like synoviocytes and synovial explants. Pharmaceuticals (Basel), 2023;16.","DOI":"10.3390\/ph16050703"},{"key":"1503_CR95","first-page":"3141","volume":"8","author":"L Zou","year":"2016","unstructured":"Zou L, Zhang G, Liu L, Chen C, Cao X. Cai. Relationship between PI3K pathway and angiogenesis in CIA rat synovium. Am J Transl Res. 2016;8:3141\u20137.","journal-title":"Am J Transl Res"},{"key":"1503_CR96","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/1040841X.2021.1876631","volume":"47","author":"S Ahlawat","year":"2021","unstructured":"Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol. 2021;47:254\u201373.","journal-title":"Crit Rev Microbiol"},{"key":"1503_CR97","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","volume":"17","author":"MM Zaiss","year":"2021","unstructured":"Zaiss MM, Joyce Wu HJ, Mauro D, Schett G. Ciccia. The gut-joint axis in rheumatoid arthritis. Nat Rev Rheumatol. 2021;17:224\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"1503_CR98","doi-asserted-by":"crossref","unstructured":"Li XL, Zhang B, Sun MJ, Bao CC, Yuan BY, Xie QF et al. Mechanism of gut microbiota and Axl\/SOCS3 in experimental autoimmune encephalomyelitis. Biosci Rep, 2019;39.","DOI":"10.1042\/BSR20190228"},{"key":"1503_CR99","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1038\/s41598-023-32527-2","volume":"13","author":"SM Yee","year":"2023","unstructured":"Yee SM, Choi H, Seon JE, Ban YJ, Kim MJ, Seo JE, et al. Axl alleviates DSS-induced colitis by preventing dysbiosis of gut microbiota. Sci Rep. 2023;13:5371.","journal-title":"Sci Rep"},{"key":"1503_CR100","doi-asserted-by":"publisher","first-page":"13091","DOI":"10.1073\/pnas.1302507110","volume":"110","author":"L Bosurgi","year":"2013","unstructured":"Bosurgi L, Bernink JH, Delgado Cuevas V, Gagliani N, Joannas L, Schmid ET, et al. Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer. Proc Natl Acad Sci U S A. 2013;110:13091\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1503_CR101","doi-asserted-by":"publisher","first-page":"e0179979","DOI":"10.1371\/journal.pone.0179979","volume":"12","author":"DJ Uribe","year":"2017","unstructured":"Uribe DJ, Mandell EK, Watson A, Martinez JD, Leighton JA, Ghosh S, et al. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer. PLoS ONE. 2017;12:e0179979.","journal-title":"PLoS ONE"},{"key":"1503_CR102","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFAs)-Mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"1503_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2020.09.008","volume":"357","author":"A Ranta","year":"2020","unstructured":"Ranta A, Kumar S. Recent advancements in role of TAM receptors on efferocytosis, viral infection, autoimmunity, and tissue repair. Int Rev Cell Mol Biol. 2020;357:1\u201319.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1503_CR104","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1161\/ATVBAHA.108.169078","volume":"28","author":"H Ait-Oufella","year":"2008","unstructured":"Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, Merval R, et al. Defective Mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:1429\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1503_CR105","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/CIRCRESAHA.117.311327","volume":"121","author":"M DeBerge","year":"2017","unstructured":"DeBerge M, Yeap XY, Dehn S, Zhang S, Grigoryeva L, Misener S, et al. MerTK cleavage on resident cardiac macrophages compromises repair after myocardial ischemia reperfusion injury. Circ Res. 2017;121:930\u201340.","journal-title":"Circ Res"},{"key":"1503_CR106","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301198","volume":"113","author":"E Wan","year":"2013","unstructured":"Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res. 2013;113:1004\u201312.","journal-title":"Circ Res"},{"key":"1503_CR107","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.RES.0000074881.56564.46","volume":"92","author":"G Collett","year":"2003","unstructured":"Collett G, Wood A, Alexander MY, Varnum BC, Boot-Handford RP, Ohanian V, et al. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res. 2003;92:1123\u20139.","journal-title":"Circ Res"},{"key":"1503_CR108","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.113.01382","volume":"62","author":"SN Batchu","year":"2013","unstructured":"Batchu SN, Hughson A, Gerloff J, Fowell DJ. Korshunov. Role of Axl in early kidney inflammation and progression of salt-dependent hypertension. Hypertension. 2013;62:302\u20139.","journal-title":"Hypertension"},{"key":"1503_CR109","doi-asserted-by":"publisher","first-page":"H1048","DOI":"10.1152\/ajpheart.00495.2015","volume":"309","author":"SN Batchu","year":"2015","unstructured":"Batchu SN, Xia J, Ko KA, Doyley MM, Abe J, Morrell CN, et al. Axl modulates immune activation of smooth muscle cells in vein graft remodeling. Am J Physiol Heart Circ Physiol. 2015;309:H1048\u201358.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1503_CR110","doi-asserted-by":"crossref","unstructured":"Yan D, Earp HS, DeRyckere D. D. K. Graham. Targeting MERTK and AXL in EGFR mutant Non-Small cell lung cancer. Cancers (Basel), 2021;13.","DOI":"10.3390\/cancers13225639"},{"key":"1503_CR111","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es-Pinto K, Leandro M, Corr\u00eaa A, Maia EP, Rodrigues L et al. A. L. A. da Costa. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl. Front Immunol, 2024;15:1380628.","DOI":"10.3389\/fimmu.2024.1380628"},{"key":"1503_CR112","doi-asserted-by":"publisher","first-page":"eadj0133","DOI":"10.1126\/scitranslmed.adj0133","volume":"16","author":"Z Pan","year":"2024","unstructured":"Pan Z, El Sharkway R, Bayoumi A, Metwally M, Gloss BS, Brink R, et al. Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Sci Transl Med. 2024;16:eadj0133.","journal-title":"Sci Transl Med"},{"key":"1503_CR113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-020-00867-5","volume":"16","author":"X Yan","year":"2021","unstructured":"Yan X, Xu Z, Li S, Yan L, Lyu G, Wang Z. Establishment and verification of an osteoporosis risk model in patients with rheumatoid arthritis: a valuable new model. Arch Osteoporos. 2021;16:3.","journal-title":"Arch Osteoporos"},{"key":"1503_CR114","doi-asserted-by":"publisher","first-page":"111671","DOI":"10.1016\/j.intimp.2024.111671","volume":"130","author":"J He","year":"2024","unstructured":"He J, Zhao D, Peng B, Wang X, Wang S, Zhao X, et al. A novel mechanism of vildagliptin in regulating bone metabolism and mitigating osteoporosis. Int Immunopharmacol. 2024;130:111671.","journal-title":"Int Immunopharmacol"},{"key":"1503_CR115","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/acr.22835","volume":"68","author":"CC Mok","year":"2016","unstructured":"Mok CC, Ding HH, Kharboutli M, Mohan C, Axl. Ferritin, Insulin-Like growth factor binding protein 2, and tumor necrosis factor receptor type II as biomarkers in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2016;68:1303\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1503_CR116","doi-asserted-by":"publisher","first-page":"1244170","DOI":"10.3389\/fimmu.2023.1244170","volume":"14","author":"E Ubil","year":"2023","unstructured":"Ubil E. Zahid. Structure and functions of Mer, an innate immune checkpoint. Front Immunol. 2023;14:1244170.","journal-title":"Front Immunol"},{"key":"1503_CR117","doi-asserted-by":"publisher","first-page":"e13064","DOI":"10.1111\/eci.13064","volume":"49","author":"S Gong","year":"2019","unstructured":"Gong S, Xu Z, Liu Y, Xing L, Ma J, Yu C, et al. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis. Eur J Clin Invest. 2019;49:e13064.","journal-title":"Eur J Clin Invest"},{"key":"1503_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imr.12522","volume":"276","author":"YT Akalu","year":"2017","unstructured":"Akalu YT, Rothlin CV, Ghosh S. TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint Blockade for cancer therapy. Immunol Rev. 2017;276:165\u201377.","journal-title":"Immunol Rev"},{"key":"1503_CR119","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/s41467-025-58179-6","volume":"16","author":"S Loges","year":"2025","unstructured":"Loges S, Heuser M, Chromik J, Sutamtewagul G, Kapp-Schwoerer S, Crugnola M, et al. Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b\/2a trial. Nat Commun. 2025;16:2846.","journal-title":"Nat Commun"},{"key":"1503_CR120","doi-asserted-by":"crossref","unstructured":"Yan D, Huelse JM, Kireev D, Tan Z, Chen L, Goyal S et al. MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer. J Clin Invest, 2022;132.","DOI":"10.1172\/JCI150517"},{"key":"1503_CR121","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/cac2.12040","volume":"40","author":"Y Yang","year":"2020","unstructured":"Yang Y, Ji N, Cai CY, Wang JQ, Lei ZN, Teng QX, et al. Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor. Cancer Commun (Lond). 2020;40:285\u2013300.","journal-title":"Cancer Commun (Lond)"},{"key":"1503_CR122","doi-asserted-by":"crossref","unstructured":"Chang YC, Liu CT, Yu CY. W. W. Sung. NPS-1034 exerts therapeutic efficacy in renal cell carcinoma through multiple targets of MET, AXL, and TNFRSF1A signaling in a metastatic model. Cells, 2024;13.","DOI":"10.3390\/cells13201713"},{"key":"1503_CR123","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/1541-7786.MCR-21-0444","volume":"20","author":"D Zd\u017calik-Bielecka","year":"2022","unstructured":"Zd\u017calik-Bielecka D, Kozik K, Po\u015bwiata A, Jastrz\u0119bski K, Jakubik M. Mi\u0105czy\u0144ska. Bemcentinib and gilteritinib inhibit cell growth and impair the Endo-Lysosomal and autophagy systems in an AXL-Independent manner. Mol Cancer Res. 2022;20:446\u201355.","journal-title":"Mol Cancer Res"},{"key":"1503_CR124","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Suresh D, Zambre A, Yadavilli S, Ghoshdastidar S, Upendran A et al. Synergistic Inhibition of drug resistant KRAS mutant Non-Small cell lung cancer by Co-Targeting AXL and SRC. Cancers (Basel), 2025;17.","DOI":"10.3390\/cancers17030490"},{"key":"1503_CR125","doi-asserted-by":"publisher","first-page":"100554","DOI":"10.1016\/j.xcrm.2022.100554","volume":"3","author":"H Li","year":"2022","unstructured":"Li H, Liu Z, Liu L, Zhang H, Han C, Girard L, et al. AXL targeting restores PD-1 Blockade sensitivity of STK11\/LKB1 mutant NSCLC through expansion of TCF1(+) CD8 T cells. Cell Rep Med. 2022;3:100554.","journal-title":"Cell Rep Med"},{"key":"1503_CR126","doi-asserted-by":"crossref","unstructured":"Wu Q, Li X, Yang Y, Huang J, Yao M, Li J et al. MICA\u2009+ tumor cell upregulated Macrophage-Secreted MMP9 via PROS1-AXL axis to induce tumor immune escape in advanced hepatocellular carcinoma (HCC). Cancers (Basel), 2024;16.","DOI":"10.3390\/cancers16020269"},{"key":"1503_CR127","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s10637-017-0470-z","volume":"35","author":"M Mori","year":"2017","unstructured":"Mori M, Kaneko N, Ueno Y, Yamada M, Tanaka R, Saito R, et al. Gilteritinib, a FLT3\/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia. Invest New Drugs. 2017;35:556\u201365.","journal-title":"Invest New Drugs"},{"key":"1503_CR128","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/1535-7163.MCT-21-0293","volume":"21","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Arner EN, Rizvi A, Toombs JE, Huang H, Warner SL, et al. AXL inhibitor TP-0903 reduces metastasis and therapy resistance in pancreatic cancer. Mol Cancer Ther. 2022;21:38\u201347.","journal-title":"Mol Cancer Ther"},{"key":"1503_CR129","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejmech.2019.01.065","volume":"166","author":"L Tan","year":"2019","unstructured":"Tan L, Zhang Z, Gao D, Chan S, Luo J, Tu ZC, et al. Quinolone antibiotic derivatives as new selective Axl kinase inhibitors. Eur J Med Chem. 2019;166:318\u201327.","journal-title":"Eur J Med Chem"},{"key":"1503_CR130","doi-asserted-by":"publisher","first-page":"116437","DOI":"10.1016\/j.bmc.2021.116437","volume":"49","author":"PS Ng","year":"2021","unstructured":"Ng PS, Foo K, Sim S, Wang G, Huang C, Tan LH, et al. Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors. Bioorg Med Chem. 2021;49:116437.","journal-title":"Bioorg Med Chem"},{"key":"1503_CR131","doi-asserted-by":"publisher","first-page":"112942","DOI":"10.1016\/j.intimp.2024.112942","volume":"142","author":"F Chen","year":"2024","unstructured":"Chen F, Li Y, Zhao L, Lin C, Zhou Y, Ye W, et al. Anti-inflammatory effects of MerTK by inducing M2 macrophage polarization via PI3K\/Akt\/GSK-3\u03b2 pathway in gout. Int Immunopharmacol. 2024;142:112942.","journal-title":"Int Immunopharmacol"},{"key":"1503_CR132","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/cmdc.201600589","volume":"12","author":"AL McIver","year":"2017","unstructured":"McIver AL, Zhang W, Liu Q, Jiang X, Stashko MA, Nichols J, et al. Discovery of macrocyclic pyrimidines as MerTK-Specific inhibitors. ChemMedChem. 2017;12:207\u201313.","journal-title":"ChemMedChem"},{"key":"1503_CR133","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-18-2614","volume":"79","author":"C Kasikara","year":"2019","unstructured":"Kasikara C, Davra V, Calianese D, Geng K, Spires TE, Quigley M, et al. Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances Anti-PD-1 mAb efficacy in a murine model of Triple-Negative breast cancer. Cancer Res. 2019;79:2669\u201383.","journal-title":"Cancer Res"},{"key":"1503_CR134","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1158\/1535-7163.MCT-22-0262","volume":"22","author":"J Hsu","year":"2023","unstructured":"Hsu J, Chong C, Serrill J, Goon L, Balayan J, Johnson EN, et al. Preclinical characterization of XL092, a novel receptor tyrosine kinase inhibitor of MET, VEGFR2, AXL, and MER. Mol Cancer Ther. 2023;22:179\u201391.","journal-title":"Mol Cancer Ther"},{"key":"1503_CR135","doi-asserted-by":"publisher","first-page":"13524","DOI":"10.1021\/acs.jmedchem.1c00920","volume":"64","author":"W McCoull","year":"2021","unstructured":"McCoull W, Boyd S, Brown MR, Coen M, Collingwood O, Davies NL, et al. Optimization of an Imidazo[1,2-a]pyridine series to afford highly selective type I1\/2 dual Mer\/Axl kinase inhibitors with in vivo efficacy. J Med Chem. 2021;64:13524\u201339.","journal-title":"J Med Chem"},{"key":"1503_CR136","doi-asserted-by":"publisher","first-page":"10906","DOI":"10.1021\/acs.jmedchem.4c00400","volume":"67","author":"MC Li","year":"2024","unstructured":"Li MC, Lai YL, Kuo PH, Reddy JS, Chen CM, Manimala J, et al. Discovery of dual MER\/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment. J Med Chem. 2024;67:10906\u201327.","journal-title":"J Med Chem"},{"key":"1503_CR137","doi-asserted-by":"publisher","first-page":"17000","DOI":"10.1021\/acs.jmedchem.4c01450","volume":"67","author":"Y Yu","year":"2024","unstructured":"Yu Y, Jang M, Miyashiro J, Clark RF, Zhu GD, Gong J, et al. Discovery of A-910, a highly potent and orally bioavailable dual MerTK\/Axl-Selective tyrosine kinase inhibitor. J Med Chem. 2024;67:17000\u201332.","journal-title":"J Med Chem"},{"key":"1503_CR138","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41401-022-01029-8","volume":"44","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Park M, Kim HY, Kim JK, Kim WK, Lim SC, et al. Circulating small extracellular vesicles promote proliferation and migration of vascular smooth muscle cells via AXL and MerTK activation. Acta Pharmacol Sin. 2023;44:984\u201398.","journal-title":"Acta Pharmacol Sin"},{"key":"1503_CR139","doi-asserted-by":"crossref","unstructured":"Zd\u017calik-Bielecka D, Po\u015bwiata A, Kozik K, Jastrz\u0119bski K, Schink KO, Brewi\u0144ska-Olchowik M et al. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion. Proc Natl Acad Sci U S A, 2021;118.","DOI":"10.1073\/pnas.2024596118"},{"key":"1503_CR140","unstructured":"Caldwell AS, Milner DC, Mehta NB, Marin AI, Gill ZS. N. Manoharan. MERTK inhibitor associated retinal toxicity in a human. Retin Cases Brief Rep; 2024."},{"key":"1503_CR141","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1158\/1535-7163.MCT-13-0040","volume":"12","author":"S Christoph","year":"2013","unstructured":"Christoph S, Deryckere D, Schlegel J, Frazer JK, Batchelor LA, Trakhimets AY, et al. UNC569, a novel small-molecule Mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo. Mol Cancer Ther. 2013;12:2367\u201377.","journal-title":"Mol Cancer Ther"},{"key":"1503_CR142","doi-asserted-by":"publisher","first-page":"43908","DOI":"10.1038\/srep43908","volume":"7","author":"SG Kimani","year":"2017","unstructured":"Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, Comollo T, et al. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity. Sci Rep. 2017;7:43908.","journal-title":"Sci Rep"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01503-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01503-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01503-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:04:28Z","timestamp":1763553868000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01503-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1503"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01503-w","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}